HeartMate 3左心室辅助装置外源性流出道移植物梗阻:最新综述
本综述聚焦于唯一商用耐久性左心室辅助装置HeartMate 3使用中发现的流出道移植物梗阻,特别是泵出口处移植物与弯曲保护套之间无细胞生物碎屑积聚所致的外源性梗阻。该并发症起病隐匿、发生于术后晚期、诊断困难,可导致显著病残率和死亡率,文章概述了诊断、治疗和预防策略。
要点
- 外源性流出道移植物梗阻与泵出口处弯曲保护套内无细胞生物碎屑积聚相关。
- 该并发症起病隐匿、发生于术后晚期,诊断具有挑战性。
- 该并发症可导致显著病残率和死亡率。
核心结论
- 外源性流出道移植物梗阻是HeartMate 3左心室辅助装置使用中需关注的泵功能障碍类别,尤其与弯曲保护套处生物碎屑积聚相关。
研究设计与样本
- 本文为最新综述,总结HeartMate 3左心室辅助装置外源性流出道移植物梗阻的相关文献。
主要发现
- 外源性流出道移植物梗阻表现为泵出口处移植物与弯曲保护套之间无细胞生物碎屑积聚。
- 该过程起病隐匿、发生于术后晚期、诊断困难,可导致显著病残率和死亡率。
临床怎么用
- 综述概述了该并发症的诊断、治疗和预防策略。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
While notable improvements in survival, the incidence of hemocompatibility-related adverse events, hospitalizations, and cost have been demonstrated with the only commercially available durable left ventricular assist device, a category of pump malfunctions characterized by outflow graft obstruction has been noted with broader use and clinical follow-up of recipients of this technology. Of particular concern is the accumulation of acellular biodebris between the outflow graft and bend relief covering the outflow graft at its origin with the pump (which we term extrinsic outflow graft obstruction at the bend relief). This process tends to be insidious, occurs late in the postoperative course, can be challenging to diagnose, and can result in significant morbidity and mortality. Herein, we provide a review of this complication and outline diagnostic, treatment, and preventive strategies.
引用
- Goldstein DJ, Kanwar M, Cowger J, et al. Extrinsic outflow graft obstruction of the HeartMate 3 LVAD: A state-of-the-art review. J Heart Lung Transplant. 2024. PMID: 39019352. doi:10.1016/j.healun.2024.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。